Eargo Inc (DELISTED) (EAR:DL)
2.57
0.00 (0.00%)
USD |
NASDAQ |
Feb 23, 16:00
Eargo Revenue (Quarterly): 8.27M for Sept. 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 8.27M |
| June 30, 2023 | 8.108M |
| March 31, 2023 | 11.81M |
| December 31, 2022 | 12.92M |
| September 30, 2022 | 7.908M |
| June 30, 2022 | 7.247M |
| March 31, 2022 | 9.176M |
| December 31, 2021 | 10.06M |
| September 30, 2021 | -22.87M |
| Date | Value |
|---|---|
| June 30, 2021 | 22.88M |
| March 31, 2021 | 22.05M |
| December 31, 2020 | 22.38M |
| September 30, 2020 | 18.19M |
| June 30, 2020 | 15.92M |
| March 31, 2020 | 12.67M |
| December 31, 2019 | 10.62M |
| September 30, 2019 | 7.73M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-22.87M
Minimum
Sep 2021
22.88M
Maximum
Jun 2021
10.89M
Average
10.62M
Median
Dec 2019
Revenue (Quarterly) Benchmarks
| Ainos Inc | 0.0199M |
| OpGen Inc | 0.699M |
| Zomedica Corp | 7.337M |
| LENSAR Inc | 12.10M |
| Intelligent Bio Solutions Inc | 0.7641M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.33M |
| Total Expenses (Quarterly) | 25.34M |
| EPS Diluted (Quarterly) | -0.83 |
| Gross Profit Margin (Quarterly) | 52.39% |
| Profit Margin (Quarterly) | -209.5% |